[Aerpio Therapeutics] closed $9M funding[Aerpio Therapeutics] closed $9M funding

Aerpio Therapeutics is a clinical-stage biotechnology company focused on the development of novel small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing.

Founded       2011

Country        USA

City               Cincinnati

Funding        $9M


[adyen action=”checkout_button”]





Author:
Investor & Serial Startupper ;-))

Leave a Reply

Registrations
Password must be at least 7 characters long.
Please login to view this page.
Please login to view this page.
Please login to view this page.